The effects of soy extract on the uterus of castrated adult rats

Maturitas

Volumn 56, Issue 2, 2007, Pages 173-183

  Mosquette, Rejane ^a   Simões, Manuel de Jesus ^a   da Silva, Ismael Dale Cotrim Guerreiro ^a   Oshima, Celina Tizuko Fujiyama ^a   Oliveira Filho, Ricardo Martins ^b   Haidar, Mauro Abi ^a   Simões, Ricardo Santos ^a   Baracat, Edmund Chada ^a,b   Soares, José Maria ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Castrated rat; Endometrium; Isoflavones; Morphology; Soy extract; Uterus; VEGF

Indexed keywords

17ALPHA ESTRADIOL; CONJUGATED ESTROGEN; DAIDZEIN; DIHYDROEQUILIN; EQUILIN; ESTRONE; GENISTEIN; GLYCITEIN; ISOFLAVONE DERIVATIVE; PROPYLENE GLYCOL; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CASTRATED FEMALE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; ENDOMETRIUM CELL; FEMALE; HISTOLOGY; LOW DRUG DOSE; MYOMETRIUM; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RANDOMIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SOYBEAN; STROMA; UTERUS; UTERUS HORN; WISTAR RAT;

ANIMALS; BODY WEIGHT; ESTRADIOL; FEMALE; ORGAN SIZE; OVARIECTOMY; PLANT EXTRACTS; PROGESTERONE; PROLIFERATING CELL NUCLEAR ANTIGEN; RANDOM ALLOCATION; RATS; RATS, WISTAR; SOYBEANS; UTERUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA; EQUIDAE; GREAT ISLAND VIRUS; RATTUS; RATTUS NORVEGICUS;

EID: 33846056950     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2006.07.011     Document Type: Article

References (51)

1. Judd H.L. Estrogen replacement therapy: indications and complications. Ann Intern Med 98 (1983) 195-205
2. Erlite Y. Association of waking episodes with menopausal hot flushes. JAMA 245 (1981) 1741-1744
3. Semmens J.P., and Wagner G. Estrogen reproduction and vaginal function in postmenopausal women. JAMA 248 (1982) 445-448
4. Woodruf J.D., Pickard J.H., and The Menopause Study Group. Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyproesterone acetate or conjugated estrogens alone. Am J Obstet Gynecol 170 (1994) 1213
5. Collaborative Group on Hormonal Factors in breast cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer. Lancet 350 (1997) 1047
6. WHI-Writing Group for the WHI (Women's Health Initiative) Investigators. Risk and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Iniciative randomized controlled trial. JAMA 288 (2002) 321-333
7. Nachtigall L.E. Isoflavones in the management of menopause. J Br Menopause Soc S1 (2001) 8-11
8. Han K.K., Soares Jr. J.M., Haidar M.A., de Lima G.R., and Baracat E.C. Benefits of soy isoflavone therapeutic regimen on menopausal symptoms. Obstet Gynecol 99 (2002) 389-394
9. Boulet M., Oddens B., Lehert P., Vemer H., and Visser A. Climacteric and menopause in seven south-east Asian countries. Maturitas 19 (1994) 157-176
10. Lock M. Encounters with aging: mythologies of menopause in Japan and North America (1993), University of California Press, Berkeley, CA
11. Notelovitz M. Estrogen replacement therapy indications, contraindications and agent selection. Am J Obstet Gynecol 167 (1989) 8-17
12. Rekers H. Mastering the menopause. In: Burger H., and Boulet M. (Eds). A portrait of the menopause (1991), The Parthenon Publishing Group, Park Bridge, New Jersey 23-43
13. Adlercreutz H. Phytoestrogens: epidemiology and a possible role in cancer protection. Environ Health Perspect 103 (1995) 103-112
14. Grady D., Rubin S., and Petitti D. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 117 (1992) 1016-1037
15. Vincent A., and Fitzpatrick L.A. Soy isoflavones: are they useful in menopause?. Mayo Clin Proc 75 (2000) 1174-1184
16. Kuiper G.G., Lemmen J.G., Carlsson B., et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 130 (1998) 4252-4263
17. Cline J.M., Paschold J.C., Anthony M.S., Obasanjo I.O., and Adams M.R. Effects of hormonal therapies and dietary soy phytoestrogens on vaginal cytology in surgically postmenopausal macaques. Fertil Steril 65 5 (1996) 1031-1035
18. Erlandsson M.C., Islander U., Moverare S., Ohlsson C., and Carlsten H. Estrogenic agonism and antagonism of the soy isoflavone genistein in uterus, bone and lymphopoiesis in mice. APMIS 113 5 (2005) 317-323
19. Kuiper G.G., Carlsson B., Grandien K., et al. Comparison of the lig and binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138 (1997) 863-870
20. Makela S., Davis V.L., Tally W.C., et al. Dietary estrogens act through estrogen receptor-mediated processes and show no antiestrogenicity in cultured breast cancer cells. Environ Health Perspect 102 (1994) 572-578
21. Santell R.C., Chang Y.C., Nair M.G., and Helferich W.G. Dietary genistein exerts estrogenic effects upon the uterus, mammary gland and the hypothalamic/pituitary axis in rats. J Nutr 127 (1997) 263-269
22. Mikisicek R. 1994 Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor. J Steroid Biochem Mol Biol 49 (1997) 153-160
23. Schonherr E., Kinsella M., and Wight T. Genistein selectively inhibits platelet derived growth factor-stimulated versican biosynthesis in monkey arterial smooth muscle cells. Arch Biochem Biophys 339 (1997) 353-361
24. Diel P., Smolnikar K., Schulz T., Laudenbach-Leschowski U., Michna H., and Vollmer G. Phytoestrogens and carcinogenesis-differential effects of genistein in experimental models of normal and malignant rat endometrium. Hum Reprod 16 (2001) 997-1006
25. Makela S.I., Pylkkanen L.H., Santti R.S., and Adlercreutz H. Dietary soybean may be antiestrogenic in male mice. J Nutr 125 (1995) 437-445
26. Hsieh C.Y., Santell R.C., Haslam S.Z., and Helferich W.G. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res 58 (1998) 3833-3838
27. Allred C.D., Allred K.F., Ju Y.H., et al. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumour following ovariectomy of Sprague-Dawley rats. Carcinogenesis 25 (2004) 211-228
28. Kaari C., Haidar M.A., Soares Jr. J.M., et al. Randomized clinical trial comparing conjugated equine estrogens and isoflavones in postmenopausal women: a pilot study. Maturitas 53 1 (2006) 49-58
29. Morton M.S., Arisaka O., Miyake N., Morgan L.D., and Evans B.A. Phytoestrogen concentrations in serum from Japanese men and women over forty years of age. J Nutr 132 (2002) 3168-3171
30. Yamamoto S., Sobue T., Sasaki S., et al. Validity and reproducibility of a self-administered food frequency questionnaire to assess isoflavone intake in a Japanese population in comparison with dietary records in blood and urine isoflavones. J Nutr 131 (2001) 2741-2747
31. McClain R.M., Wolzb E., Davidovichc A., Pfannkuchd F., Edwardsb J.A., and Bauschb J. Acute, subchronic and chronic safety studies with genistein in rats. Food Chem Toxicol 44 1 (2006) 56-80
32. Buteau-Lozano H., Ancelin M., and Lardeux B. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta. Cancer Res 62 (2002) 4977-4984
33. Koos R.D., Kazi A.A., Roberson M.S., and Jones J.M. New insight into the transcriptional regulation of vascular endothelial growth factor expression in the endometrium by estrogen and relaxin. Ann N Y Acad Sci 1041 (2005) 233-247
34. Brzezinski A., Adlercreutz H., Shaoul R., Rösler A., Shmueli A., and Tanus Schenker J.G. Short-term effects of phytoestrogen-rich diet on postmenopausal women. Menopause 4 (1997) 89-94
35. Faure E.D., Chantre P., and Mares P. Effects of a standardized soy extract on hot flushes: a multicenter, double-blind, randomized, placebo-controlled study. Menopause 9 (2002) 324-329
36. Andrade P.M., Silva I.D., Borra R.C., Lima G.R., and Baracat E.C. Estrogen and selective estrogen receptor modulator regulation of insulin-like growth factor binding protein 5 in the rat uterus. Gynecol Endocrinol 16 (2002) 265-270
37. Rossi A.G., Soares Jr. J.M., Motta E.L., et al. Metoclopramide-induced hyperprolactinemia affects mouse endometrial morphology. Gynecol Obstet Invest 54 (2002) 185-190
38. Petri Nahas E., Nahas Neto J., De Luca L., Traiman P., Pontes A., and Dalben I. Benefits of soy germ isoflavones in postmenopausal women with contraindication for conventional hormone replacement therapy. Maturitas 48 (2004) 372-380
39. Diel P., Smolnikar K., Schulz T., Laudenbach-Leschowski U., Michna H., and Vollmer G. Phytoestrogens and carcinogenesis-differential effects of genistein in experimental models of normal and malignant rat endometrium. Hum Reprod 16 (2001) 997-1006
40. Caldarelli A., Diel P., and Vollmer G. Effect of phytoestrogens on gene expression of carbonic anhydrase II in rat uterus and liver. J Steroid Biochem Mol Biol 97 (2005) 251-256
41. Lephart E.D., Setchell K.D., Handa R.J., and Lund T.D. Behavioral effects of endocrine-disrupting substances: phytoestrogens. ILAR J. 45 (2004) 443-454
42. Axelson M., Sjovall J., Gustafsson B.E., and Setchell K.D. Soya-a dietary source of the non-steroidal oestrogen equol in man and animals. J Endocrinol 102 (1984) 49-56
43. Pelissero C., Bennetau B., Babin P., Le Menn F., and Dunogues J. The estrogenic activity of certain phytoestrogens in the Siberian sturgeon Acipenser baeri. J Steroid Biochem Mol Biol 38 (1991) 293-299
44. Hyder S.M., Nawaz Z., Chiappetta C., and Stangel G.M. Endocrinologh identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor. Cancer Res 60 (2000) 3183-3190
45. Dvorak H.F., Brown L.F., Detmar M., and Dvorak A.M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146 (1995) 1029-1039
46. Hyder S.M., and Stancel G.M. Regulation of angiogenic growth factors in the female reproductive tract by estrogens and progestins. Mol Endocrinol 13 (1999) 806-811
47. Hanstein B., Djahansouzi S., Dall P., Beckmann M.W., and Bender H.G. Insights into the molecular biology of the estrogen receptor define novel therapeutic targets for breast cancer. Eur J Endocrinol 150 (2004) 243-255
48. Okura A., Arakawa H., Oka H., Yoshinari T., and Monden Y. Effect of genistein on topoisomerase activity and on the growth of [VAL12] Ha-ras-transformed NIH 3T3 cells. Biochem Biophys Res Commun 157 (1988) 183-189
49. Tripathi Y.B., Lim R.W., Fernandez-Gallardo S., Kandala J.C., Guntaka R.V., and Shukla S.D. Involvement of tyrosine kinase and protein kinase C in platelet-activating-factor-induced c-fos gene expression in A-431 cells. Biochem J 286 (1992) 527-533
50. Akiyama T., Ishida J., Nakagawa S., et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262 (1987) 5592-5595
51. Unfer V., Casini M.L., Costabile L., Mignosa M., Gerli S., and Di Renzo G.C. Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study. Fertil Steril 82 (2004) 145-148